Rituximab maintenance did not significantly extend PFS in follicular lymphoma Healio A brief induction with rituximab, fludarabine, mitoxantrone and dexamethasone followed by rituximab consolidation was associated with high complete response and PFS rates in older patients with follicular lymphoma, according to results of a phase 3 study. |
